WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Monday, March 28, 2016

The Michael J. Fox Foundation Announces Six Academic Centers Chosen for 2017-2019 Edmond J. Safra Fellowship in Movement Disorders


NEW YORK, March 28, 2016 

The Michael J. Fox Foundation for Parkinson's Research, in collaboration with its longtime supporter and partner the Edmond J. Safra Foundation, has selected six academic centers in the United States and Germany to host the second class of the Edmond J. Safra Fellowship in Movement Disorders.
The six centers selected for the 2017-2019 Edmond J. Safra Fellowship in Movement Disorders class are:

  Icahn School of Medicine at Mount Sinai in New York
  University of California San Francisco
  Rush University in Chicago
  University of Pennsylvania in Philadelphia
  University of Rochester in Rochester, New York
  University of Tübingen in Germany

By increasing resources for specialized training for clinician-researcher neurologists, this program aims to grow the global base of movement disorder specialists treating people with Parkinson's and contributing to research toward breakthrough treatments for the disease.
"This program is designed to give people with Parkinson's the best possible care," said Mrs. Lily Safra, chairwoman of the Edmond J. Safra Foundation. "These prestigious institutions provide fellows with expert training in the field of movement disorders, thus increasing the number of specialty physicians available to people with Parkinson's disease."
"This program trains knowledgeable specialists who provide day-to-day care to people with Parkinson's and conduct research to speed the development of new treatments," said Todd Sherer, PhD, CEO of The Michael J. Fox Foundation (MJFF). "There is a pressing need for both those sides of service as our population grows and more people age into risk of Parkinson's disease." 
A lack of available funding for fellowships historically has limited the number of openings in movement disorder specialist training programs, including programs at medical centers with the required expertise to train the next generation of specialists.
A committee of advisors selected by MJFF chose the six centers. Five of the six centers will now identify a fellow to begin two years of training in July 2017. The University of Tübingen has identified a fellow to begin later in 2016.

Impact of Clinician-Researchers Specializing in Movement Disorders

In addition to delivering expert care to individual patients, clinician-researcher movement disorder specialists improve the landscape of Parkinson's care overall. The clinicians trained through the Edmond J. Safra Fellowship in Movement Disorders will design and conduct studies with their patients' unmet needs in mind. From the front lines, they are poised to observe trends and nuances of the patient experience that can lead to investigations toward greater understanding of disease and open new avenues to better therapies. 
Patients are specialists' greatest partners in research. These doctors are aware of (and often leaders of) ongoing clinical trials and research studies, putting them in a position to educate their patients about participating in research — a powerful opportunity to be part of the quest for a cure.
"We're grateful to Lily Safra and the Edmond J. Safra Foundation for their vision in seeding the pipeline of future specialists in the treatment of Parkinson's disease," said Michael J. Fox. "It was gratifying to see clinicians and researchers respond with enthusiasm when the program launched last year — we can't wait to see what the future may hold."

Dedication to Parkinson's Care and Research

The late banker and philanthropist Edmond J. Safra's namesake Foundation has long made Parkinson's disease care and research one of its top priorities. Mrs. Safra, Chairwoman of the Edmond J. Safra Foundation, has been an MJFF Board member since 2001.
In addition to generous gifts to centers and programs providing direct care to people with Parkinson's disease, Lily Safra and her Foundation have driven vital scientific investigation into new treatments. The fellowship is the latest among many partnerships between the Edmond J. Safra Foundation and MJFF, including the Edmond J. Safra Core Programs for PD Research, one of MJFF's central grantmaking avenues to support high-impact Parkinson's research projects.

About The Michael J. Fox Foundation for Parkinson's Research

As the world's largest nonprofit funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers. In addition to funding more than $600 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson's disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world.


About the Edmond J. Safra Philanthropic Foundation
Edmond J. Safra, one of the 20th century's most accomplished bankers and a devoted philanthropist, established a major philanthropic foundation to ensure that individuals and organizations would continue to receive his assistance and encouragement for many years to come. Under the chairmanship of his beloved wife Lily, the Edmond J. Safra Philanthropic Foundation draws continuing inspiration from its founder's life and values, and supports hundreds of organizations in more than 40 countries around the world. Its work encompasses four areas: Education; Science and Medicine; Religion; and Humanitarian Assistance, Culture and Social Welfare. The Foundation has provided significant funding for Parkinson's disease research and patient care at dozens of hospitals and institutes in places as varied as Natal (Brazil), Toronto, New York, Grenoble, Paris, London and Jerusalem.

No comments:

Post a Comment